diabetes management

By Heather Mack 03:49 pm December 7, 2016
Medical device maker Medtronic has teamed up with Fitbit to integrate physical activity data with blood glucose levels into one streamlined application.  People living with type 2 diabetes who use Medtronic's iPro2 continuous glucose monitoring system and its companion app, iPro2 myLog, will now be able to have their Fitbit data automatically synced to the app, enabling them to easily see the...
By Jonah Comstock 01:06 pm December 7, 2016
BioTelemetry, formerly known as CardioNet, has acquired TelCare, a diabetes management technology company with the distinction of having had the first FDA-cleared, cellular-connected glucometer. BioTelemetry paid $7 million in cash with the potential for additional performance-based earn-outs of up to $5 million, also in cash. Both BioTelemetry and TelCare are veterans of the early days of the...
By Heather Mack 02:20 pm December 2, 2016
Germantown, Maryland-based Senseonics, which is working on a long-term implantable continuous glucose monitor called Eversense, has expanded its exclusive distribution agreement with Roche. Now, Roche will have exclusive rights to promote, market and sell the Eversense product line to diabetes clinics and patients in in most of Europe (excluding Scandinavia and Finland), the Middle East (except...
By Heather Mack 01:33 pm November 11, 2016
Israel-based DarioHealth, which makes a smartphone-connected blood glucose monitor, has made significant headway in the US, Australian and Canadian markets, seling 5,500 devices in the US this quarter and 8,500 worldwide. The company launched in the US in March, and quickly built up a customer base with more than 100 percent increase in growth by the second quarter. Coasting on that wave of new...
By Heather Mack 01:04 pm October 19, 2016
Milpitas, California-based diabetes management company Bigfoot Biomedical has raised $35.5 million in Series A funding in a round with participation from Cormorant Asset Management, Senvest Capital and Visionnaire Ventures. The funding will be used to further develop the company’s connected, automated insulin delivery service. Bigfoot bills itself as “drawing a circle around everything that it...
By Heather Mack 03:44 pm October 7, 2016
As we take a look at the devices that received FDA clearance in 2016's third quarter, we're also considering that the last few months have been a time of change at the Food and Drug Administration, as regulators are beginning to make updates in their system to accomodate all the digital health tools we're seeing.  In June, the FDA offered up a draft guidance document designed to help medical...
By Jonah Comstock 04:12 pm September 13, 2016
In rural Mississippi, where almost 65 percent of the state's counties are more than a 40 minute drive from specialty care and 68 percent of the providers are in urban areas even though 64 percent of the patients are in rural areas, telehealth takes on an added importance.  Michael Adcock, and administrator at the University of Mississippi Medical Center's Center for Telehealth spoke at the Pop...
By Heather Mack 01:51 am August 16, 2016
Digital patient engagement company HealthPrize Technologies has partnered with Walgreens to offer its medication adherence platform on the drugstore chain’s website. The program will be offered to patients filling certain brand-name prescriptions for chronic conditions, starting with diabetes and eventually expanding to others. The platform will be web-based, but Walgreen's site is optimized for...
By Jonah Comstock 10:38 am June 13, 2016
A number of pieces of interesting health tech news came out of the 76th Annual Scientific Sessions of the American Diabetes Association, held this weekend in New Orleans. Here’s a roundup of the highlights. Updated 6/15/2016 to include some more news items. IBM’s Medtronic partnership gets a name. Information has been trickling out about Medtronic’s collaboration with IBM Watson Health that was...
By Brian Dolan 04:25 pm June 6, 2016
Next month the FDA is hosting a public advisory committee meeting to discuss a change to the intended use of Dexcom's G5 Mobile Continuous Glucose Monitoring System (CGM) device that would allow the company to market the G5 as a CGM patients can base treatment decisions on. Currently, Dexcom's CGMs are considered adjunctive devices, which means they carry an asterisk that notes they are intended...